« Teva goes for a US biosimilar | Main | Wanna scan lots of biotech news in one spot? »

02/03/2010

Teva files Amgen counters

Amgen has gone to federal court to block Teva's path with its recent BLA filing for XM02 - a potential biosimilar competitor to Amgen's Neupogen and Neulasta.  Amgen has filed a patent infringement claim against Teva in a Philadelphia court. This sets up an interesting legal battle.  See full article as reported on easy bourse.


Posted by Bruce Lehr Feb 3, 2010

Posted at 02:45 AM in Current Events, Generics & Biosimilars, Patents & Legal |

| | | Pin It!

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0120a8547bf0970b

Listed below are links to weblogs that reference Teva files Amgen counters:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

Bruce Lehr

Create Your Badge
Subscribe to this blog's feed

Recent Posts

Search

Blog powered by TypePad
Member since 12/2009

Twitter Updates

    follow me on Twitter
    Bookmark and Share
    My Photo

    About

    Archives

    More...

    Categories

    May 2013

    Sun Mon Tue Wed Thu Fri Sat
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31  

    visited 45 states (90%)
    Create your own visited map of The United States

    Innovate on Purpose

    In the Pipeline

    Life Sci VC

    PharmaGossip

    Pharmalot

    The IN VIVO Blog


    visited 6 states (46.1%)
    Create your own visited map of Canada

    visited 8 states (3.55%)
    Create your own visited map of The World or another interesting project